vs
Side-by-side financial comparison of HARROW, INC. (HROW) and REGIS CORP (RGS). Click either name above to swap in a different company.
HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $57.1M, roughly 1.6× REGIS CORP). HARROW, INC. runs the higher net margin — 7.4% vs 0.8%, a 6.6% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 22.3%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $891.0K). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 7.8%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
REGIS CORPRGSEarnings & Financial Report
Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.
HROW vs RGS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $57.1M |
| Net Profit | $6.6M | $456.0K |
| Gross Margin | 79.3% | — |
| Operating Margin | 17.5% | 10.8% |
| Net Margin | 7.4% | 0.8% |
| Revenue YoY | 33.3% | 22.3% |
| Net Profit YoY | -2.2% | -94.0% |
| EPS (diluted) | $0.20 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.1M | $57.1M | ||
| Q3 25 | $71.6M | $59.0M | ||
| Q2 25 | $63.7M | $60.4M | ||
| Q1 25 | $47.8M | $57.0M | ||
| Q4 24 | $66.8M | $46.7M | ||
| Q3 24 | $49.3M | $46.1M | ||
| Q2 24 | $48.9M | $49.4M | ||
| Q1 24 | $34.6M | $49.2M |
| Q4 25 | $6.6M | $456.0K | ||
| Q3 25 | $1.0M | $1.4M | ||
| Q2 25 | $5.0M | $116.5M | ||
| Q1 25 | $-17.8M | $250.0K | ||
| Q4 24 | $6.8M | $7.6M | ||
| Q3 24 | $-4.2M | $-853.0K | ||
| Q2 24 | $-6.5M | $91.2M | ||
| Q1 24 | $-13.6M | $-2.3M |
| Q4 25 | 79.3% | — | ||
| Q3 25 | 75.3% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 67.5% | — | ||
| Q4 24 | 78.8% | — | ||
| Q3 24 | 75.6% | — | ||
| Q2 24 | 74.4% | — | ||
| Q1 24 | 69.5% | — |
| Q4 25 | 17.5% | 10.8% | ||
| Q3 25 | 20.6% | 10.0% | ||
| Q2 25 | 17.9% | 12.1% | ||
| Q1 25 | -23.5% | 8.8% | ||
| Q4 24 | 19.3% | 11.8% | ||
| Q3 24 | 2.7% | 4.6% | ||
| Q2 24 | 3.1% | — | ||
| Q1 24 | -20.0% | 8.3% |
| Q4 25 | 7.4% | 0.8% | ||
| Q3 25 | 1.4% | 2.3% | ||
| Q2 25 | 7.8% | 192.9% | ||
| Q1 25 | -37.2% | 0.4% | ||
| Q4 24 | 10.1% | 16.4% | ||
| Q3 24 | -8.6% | -1.9% | ||
| Q2 24 | -13.2% | 184.7% | ||
| Q1 24 | -39.2% | -4.7% |
| Q4 25 | $0.20 | $0.16 | ||
| Q3 25 | $0.03 | $0.49 | ||
| Q2 25 | $0.13 | $43.67 | ||
| Q1 25 | $-0.50 | $0.08 | ||
| Q4 24 | $0.19 | $2.71 | ||
| Q3 24 | $-0.12 | $-0.36 | ||
| Q2 24 | $-0.18 | $38.40 | ||
| Q1 24 | $-0.38 | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $18.4M |
| Total DebtLower is stronger | $250.0M | $113.3M |
| Stockholders' EquityBook value | $52.4M | $188.7M |
| Total Assets | $399.5M | $588.3M |
| Debt / EquityLower = less leverage | 4.77× | 0.60× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $72.9M | $18.4M | ||
| Q3 25 | $74.3M | $16.6M | ||
| Q2 25 | $53.0M | $17.0M | ||
| Q1 25 | $66.7M | $13.3M | ||
| Q4 24 | $47.2M | $10.2M | ||
| Q3 24 | $72.6M | $6.3M | ||
| Q2 24 | $71.0M | $10.1M | ||
| Q1 24 | $76.0M | $5.9M |
| Q4 25 | $250.0M | $113.3M | ||
| Q3 25 | $347.2M | $111.3M | ||
| Q2 25 | $250.6M | $110.8M | ||
| Q1 25 | $256.9M | $112.0M | ||
| Q4 24 | $262.7M | $111.5M | ||
| Q3 24 | $230.7M | $95.2M | ||
| Q2 24 | $236.3M | $99.5M | ||
| Q1 24 | $243.4M | $179.7M |
| Q4 25 | $52.4M | $188.7M | ||
| Q3 25 | $47.0M | $187.6M | ||
| Q2 25 | $49.7M | $185.6M | ||
| Q1 25 | $56.5M | $68.6M | ||
| Q4 24 | $69.7M | $66.7M | ||
| Q3 24 | $58.0M | $56.4M | ||
| Q2 24 | $58.5M | $56.8M | ||
| Q1 24 | $60.6M | $-35.8M |
| Q4 25 | $399.5M | $588.3M | ||
| Q3 25 | $363.1M | $592.1M | ||
| Q2 25 | $345.0M | $599.0M | ||
| Q1 25 | $364.2M | $511.2M | ||
| Q4 24 | $389.0M | $530.1M | ||
| Q3 24 | $351.5M | $508.9M | ||
| Q2 24 | $306.6M | $530.5M | ||
| Q1 24 | $295.5M | $543.7M |
| Q4 25 | 4.77× | 0.60× | ||
| Q3 25 | 7.39× | 0.59× | ||
| Q2 25 | 5.05× | 0.60× | ||
| Q1 25 | 4.55× | 1.63× | ||
| Q4 24 | 3.77× | 1.67× | ||
| Q3 24 | 3.98× | 1.69× | ||
| Q2 24 | 4.04× | 1.75× | ||
| Q1 24 | 4.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | $1.7M |
| Free Cash FlowOCF − Capex | $8.1M | $891.0K |
| FCF MarginFCF / Revenue | 9.1% | 1.6% |
| Capex IntensityCapex / Revenue | 0.4% | 1.4% |
| Cash ConversionOCF / Net Profit | 1.27× | 3.65× |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | $14.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.4M | $1.7M | ||
| Q3 25 | $16.6M | $2.3M | ||
| Q2 25 | $-803.0K | $6.8M | ||
| Q1 25 | $19.7M | $6.2M | ||
| Q4 24 | $-17.8M | $2.1M | ||
| Q3 24 | $3.0M | $-1.3M | ||
| Q2 24 | $-2.7M | $5.1M | ||
| Q1 24 | $-4.6M | $-277.0K |
| Q4 25 | $8.1M | $891.0K | ||
| Q3 25 | $16.4M | $1.9M | ||
| Q2 25 | $-969.0K | $6.2M | ||
| Q1 25 | $19.5M | $5.9M | ||
| Q4 24 | $-18.3M | $1.7M | ||
| Q3 24 | $2.3M | $-1.4M | ||
| Q2 24 | $-3.1M | $5.1M | ||
| Q1 24 | $-4.7M | $-326.0K |
| Q4 25 | 9.1% | 1.6% | ||
| Q3 25 | 22.9% | 3.2% | ||
| Q2 25 | -1.5% | 10.3% | ||
| Q1 25 | 40.8% | 10.3% | ||
| Q4 24 | -27.4% | 3.6% | ||
| Q3 24 | 4.8% | -3.0% | ||
| Q2 24 | -6.3% | 10.3% | ||
| Q1 24 | -13.6% | -0.7% |
| Q4 25 | 0.4% | 1.4% | ||
| Q3 25 | 0.3% | 0.7% | ||
| Q2 25 | 0.3% | 0.9% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 0.8% | 0.9% | ||
| Q3 24 | 1.2% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.3% | 0.1% |
| Q4 25 | 1.27× | 3.65× | ||
| Q3 25 | 16.26× | 1.68× | ||
| Q2 25 | -0.16× | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | -2.62× | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HROW
Segment breakdown not available.
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
